comparemela.com
Home
Live Updates
Gilead Sciences, Inc.: Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024 : comparemela.com
Gilead Sciences, Inc.: Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research
Related Keywords
Italy
,
Switzerland
,
Foster City
,
California
,
United States
,
Milan
,
Lombardia
,
Frank Duff
,
Jacquie Ross
,
Epatitec Mettiamoci
,
Meaghan Smith
,
Gilead On Twitter Sciences
,
Nasdaq
,
Gilead Sciences In Liver Disease
,
Gilead Sciences
,
Love Your Liver Campaign
,
Drug Administration
,
European Commission
,
Gilead Public Affairs
,
Exchange Commission
,
Gilead Sciences Inc
,
World Health Organization
,
Key Findings
,
Fibrosis Studies Affirm Commitment
,
Drive Life Changing Science
,
Liver Disease
,
European Association
,
Senior Vice President
,
Virology Therapeutic Area Head
,
Hepatitisc Let
,
Enhanced Liver Fibrosis
,
Marketing Authorization
,
Great Britian
,
European Economic Area
,
Private Securities Litigation Reform Act
,
Quarterly Report
,
Ihr Portfolio
,
comparemela.com © 2020. All Rights Reserved.